Company: IXHL
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001213900-25-092837
Chunk: 693

Company: Incannex Healthcare Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 4
Chunk 693
---
B. Other Information

During the three months ended June 30, 2025, none
of our directors or officers adopted or terminated “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,”
as each term is defined in Item 408 of Regulation S-K.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent
Inspections

Not applicable.

93

PART III

Item 10. Directors, Executive Officers and Corporate Governance

The information required by this item is incorporated
herein by reference to our Proxy Statement with respect to our 2025 Annual Meeting of Stockholders to be filed with the SEC within 120
days of the end of the fiscal year covered by this Annual Report (“2025 Proxy Statement”).

Item 11. Executive and Director Compensation

The information required by this item is incorporated
herein by reference to our 2025 Proxy Statement.

Item 12. Security Ownership of Certain Beneficial Owners and Management
and Related Stockholder Matters

The information required by this item is incorporated
herein by reference to our 2025 Proxy Statement.

Item 13. Certain Relationships and Related Transactions, and Director
Independence

The information required by this item is incorporated
herein by reference to our 2025 Proxy Statement.

Item 14. Principal Accountant Fees and Services

The information required by this item is incorporated
herein by reference to our 2025 Proxy Statement.

94

PART IV

Item 15. Exhibits and Financial Statement Schedules

(a)(1)

The information
required by this item is incorporated herein by reference to the financial statements and notes thereto listed in Item 8
of Part II and included in this Annual Report.

(a)(2) Financial Statement Schedules.

All financial statement schedules have been omitted
because they are not applicable, not required or the information required is shown in the financial statements or the notes thereto.

(a)(3) Exhibits

The following is a list of exhibits filed, furnished
or incorporated by reference as part of this Annual Report. Exhibits which are incorporated herein by reference can be obtained on the
SEC website at www.sec.gov.

    Exhibit No.
     
    Description
  
    2.1
     
    Deed of Amendment and Restatement to Scheme Implementation Deed, dated September 13, 2023, between Incannex Healthcare Limited and Incannex Healthcare Inc. (incorporated by reference to